The alteration of PU.1 levels in mouse and human microglial cells affected the expression of many AD risk genes (Huang et al., 2017) and their phagocytic activity (Smith et al., 2013; Huang et al., 2017; Rustenhoven et al., 2018). Here, SPI1 is linked to Alzheimer disease.